Eribulin in soft-tissue sarcoma.

George D. Demetri, Margaret von Mehren, Robin L. Jones, Martee L. Hensley, Scott M. Schuetze, Arthur Staddon, Mohammed Milhem, Anthony Elias, Kristen Ganjoo, Hussein Tawbi, Brian A. Van Tine, Alexander Spira, Andrew Dean, Nushmia Z. Khokhar, Youn Choi Park, Roland E. Knoblauch, Trilok V. Parekh, Robert G. Maki, Shreyaskumar R. Patel, Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial Journal of Clinical Oncology. ,vol. 34, pp. 786- 793 ,(2016) , 10.1200/JCO.2015.62.4734

Yasuhiro Funahashi, Kiyoshi Okamoto, Yusuke Adachi, Taro Semba, Mai Uesugi, Yoichi Ozawa, Osamu Tohyama, Taisuke Uehara, Takayuki Kimura, Hideki Watanabe, Makoto Asano, Satoshi Kawano, Xavier Tizon, Paul J McCracken, Junji Matsui, Ken Aoshima, Kenichi Nomoto, Yoshiya Oda, None, Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models. Cancer Science. ,vol. 105, pp. 1334- 1342 ,(2014) , 10.1111/CAS.12488

Jean-Yves Blay, Stefan Sleijfer, Patrick Schöffski, Akira Kawai, Thomas Brodowicz, George D. Demetri, Robert G. Maki, International expert opinion on patient-tailored management of soft tissue sarcomas. European Journal of Cancer. ,vol. 50, pp. 679- 689 ,(2014) , 10.1016/J.EJCA.2013.11.011

Winette TA Van Der Graaf, Jean-Yves Blay, Sant P Chawla, Dong-Wan Kim, Binh Bui-Nguyen, Paolo G Casali, Patrick Schöffski, Massimo Aglietta, Arthur P Staddon, Yasuo Beppu, Axel Le Cesne, Hans Gelderblom, Ian R Judson, Nobuhito Araki, Monia Ouali, Sandrine Marreaud, Rachel Hodge, Mohammed R Dewji, Corneel Coens, George D Demetri, Christopher D Fletcher, Angelo Paolo Dei Tos, Peter Hohenberger, None, Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial The Lancet. ,vol. 379, pp. 1879- 1886 ,(2012) , 10.1016/S0140-6736(12)60651-5

Stefan Sleijfer, Isabelle Ray-Coquard, Zsuzsa Papai, Axel Le Cesne, Michelle Scurr, Patrick Schöffski, Françoise Collin, Lini Pandite, Sandrine Marreaud, Annick De Brauwer, Martine van Glabbeke, Jaap Verweij, Jean-Yves Blay, Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer―Soft Tissue and Bone Sarcoma Group (EORTC Study 62043) Journal of Clinical Oncology. ,vol. 27, pp. 3126- 3132 ,(2009) , 10.1200/JCO.2008.21.3223

Patrick Schöffski, Isabelle Laure Ray-Coquard, Angela Cioffi, Nguyen Bin Bui, Sebastian Bauer, Joerg Thomas Hartmann, Anders Krarup-Hansen, Viktor Grünwald, Raf Sciot, Herlinde Dumez, Jean-Yves Blay, Axel Le Cesne, Jantien Wanders, Carolyn Hayward, Sandrine Marreaud, Monia Ouali, Peter Hohenberger, Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes. Lancet Oncology. ,vol. 12, pp. 1045- 1052 ,(2011) , 10.1016/S1470-2045(11)70230-3

Nicholas F. Dybdal-Hargreaves, April L. Risinger, Susan L. Mooberry, Eribulin Mesylate: Mechanism of Action of a Unique Microtubule-Targeting Agent Clinical Cancer Research. ,vol. 21, pp. 2445- 2452 ,(2015) , 10.1158/1078-0432.CCR-14-3252

Javier Cortes, Joyce O'Shaughnessy, David Loesch, Joanne L Blum, Linda T Vahdat, Katarina Petrakova, Philippe Chollet, Alexey Manikas, Veronique Diéras, Thierry Delozier, Vladimir Vladimirov, Fatima Cardoso, Han Koh, Philippe Bougnoux, Corina E Dutcus, Seth Seegobin, Denis Mir, Nicole Meneses, Jantien Wanders, Chris Twelves, Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): A phase 3 open-label randomised study The Lancet. ,vol. 377, pp. 914- 923 ,(2011) , 10.1016/S0140-6736(11)60070-6

Xavier García-del-Muro, Antonio López-Pousa, Joan Maurel, Javier Martín, Javier Martínez-Trufero, Antonio Casado, Auxiliadora Gómez-España, Joaquín Fra, Josefina Cruz, Andrés Poveda, Andrés Meana, Carlos Pericay, Ricardo Cubedo, Jordi Rubió, Ana De Juan, Nuria Laínez, Juan Antonio Carrasco, Raquel de Andrés, José M. Buesa, Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study Journal of Clinical Oncology. ,vol. 29, pp. 2528- 2533 ,(2011) , 10.1200/JCO.2010.33.6107

David D'Adamo, Matthew Guo, Bartosz Chmielowski, Axel Le Cesne, George D Demetri, Shreyaskumar R Patel, Patrick Schöffski, Sant Chawla, Robert G Maki, Antoine Italiano, Hans Gelderblom, Edwin Choy, Giovanni Grignani, Veridiana Camargo, Sebastian Bauer, Sun Young Rha, Jean-Yves Blay, Peter Hohenberger, Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial The Lancet. ,vol. 387, pp. 1629- 1637 ,(2016) , 10.1016/S0140-6736(15)01283-0